As of May 29, 2025, Zosano Pharma Corp (ZSAN) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Zosano Pharma Corp's Forward P/E to Peers
To better understand Zosano Pharma Corp's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Zosano Pharma Corp (ZSAN) | - |
| Delcath Systems Inc (DCTH) | 185.47 |
| Intuitive Surgical Inc (ISRG) | 67.63 |
| Dexcom Inc (DXCM) | 41.29 |
| IDEXX Laboratories Inc (IDXX) | 40.91 |
| Boston Scientific Corp (BSX) | 34.82 |
Compared to its competitors, Zosano Pharma Corp's Forward P/E is difficult to compare due to insufficient data.